Comparative study between oxytocin and combination of tranexamic acid and ethamsylate in reducing intra-operative bleeding during emergency and elective cesarean section after 38 weeks of normal pregnancy.

Autor: Bosilah AH; Department of Obstetrics and Gynecology, Faculty of Medicine, Damietta University, Damietta, Egypt., Eldesouky E; Department of Obstetrics and Gynecology, Faculty of Medicine, Alazhar University, Cairo, Egypt., Alghazaly MM; Department of Obstetrics and Gynecology, Faculty of Medicine, Alazhar University for Girls, Cairo, Egypt., Farag E; Department of Obstetrics and Gynecology, Faculty of Medicine, Alazhar University, Cairo, Egypt., Sultan EEK; Department of Obstetrics and Gynecology, Faculty of Medicine, Alazhar University, Cairo, Egypt., Alazazy H; Department of Obstetrics and Gynecology, Faculty of Medicine, Alazhar University, Cairo, Egypt., Mohamed A; Department of Obstetrics and Gynecology, Faculty of Medicine, Alazhar University, Cairo, Egypt., Ali SMS; Department of Obstetrics and Gynecology, Faculty of Medicine, Alazhar University, Domiata, Egypt., Elsror AGA; International Islamic Center for Population Research, Alazhar University, Cairo, Egypt., Mahmoud M; Department of Obstetrics and Gynecology, Faculty of Medicine, Alazhar University, Cairo, Egypt., Abd Elhalim AEM; Department of Obstetrics and Gynecology, Faculty of Medicine, Alazhar University, Assuit, Egypt., Kamel MA; Faculty of Medicine, Fayoum University, Fayoum, Egypt. ma3701@fayoum.edu.eg., Abd-ElGawad M; Faculty of Medicine, Fayoum University, Fayoum, Egypt., Sayed FM; Faculty of Medicine, Fayoum University, Fayoum, Egypt., Bakry MS; Department of Obstetrics and Gynecology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Jazyk: angličtina
Zdroj: BMC pregnancy and childbirth [BMC Pregnancy Childbirth] 2023 Jun 12; Vol. 23 (1), pp. 433. Date of Electronic Publication: 2023 Jun 12.
DOI: 10.1186/s12884-023-05728-w
Abstrakt: Objective: Cesarean Section (CS) is associated with an increased risk of hemorrhage. Many drugs are used to decrease this risk. We aim to compare the combination of ethamsylate and tranexamic acid, oxytocin, and placebo in women undergoing CS.
Methods: We conducted a double-blinded, randomized, placebo-controlled trial between October and December 2020 in four university hospitals in Egypt. The study included all pregnant women in labor without any complications who accepted to participate in the study between October and December 2020. The participants were divided into three groups. The subjects were randomly allocated to receive either oxytocin (30 IU in 500 ml normal saline during cesarean section), combined one gram of tranexamic acid with 250 mg of ethamsylate once before skin incision, or distilled water. Our main outcome was the amount of blood loss during the operation. The secondary outcomes were the need for blood transfusion, hemoglobin and hematocrit changes, hospital stay, operative complications, and the need for a hysterectomy. The one-way ANCOVA test was used to compare the quantitative variables between the three groups while the Chi-square test was used to compare the qualitative variables. Post hoc analysis then was performed to compare the difference between every two groups regarding the quantitative variables.
Results: Our study included 300 patients who were divided equally into three groups. Tranexamic acid with ethamsylate showed the least intra-operative blood loss (605.34 ± 158.8 ml) compared to oxytocin (625.26 ± 144.06) and placebo (669.73 ± 170.69), P = 0.015. In post hoc analysis, only tranexamic acid with ethamsylate was effective in decreasing the blood loss compared to placebo (P = 0.013); however, oxytocin did not reduce blood loss compared to saline (P = 0.211) nor to tranexamic acid with ethamsylate (P = 1). Other outcomes and CS complications showed no significant difference between the three groups except for post-operative thrombosis which was significantly higher in the tranexamic and ethamsylate group, P < 0.00001 and the need for a hysterectomy which was significantly increased in the placebo group, P = 0.017.
Conclusion: The combination of tranexamic acid and ethamsylate was significantly associated with the least amount of blood loss. However, in pairwise comparisons, only tranexamic acid with ethamsylate was significantly better than saline but not with oxytocin. Both oxytocin and tranexamic acid with ethamsylate were equally effective in reducing intra-operative blood loss and the risk of hysterectomy; however, tranexamic acid with ethamsylate increased the risk of thrombotic events. Further research with a larger number of participants is needed.
Trial Registration: The study was registered on Pan African Clinical Trials Registry with the following number: PACTR202009736186159 and was approved on 04/09/2020.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje